These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Weak androgen levels, glucocorticoid therapy, and bone mineral density in postmenopausal women with rheumatoid arthritis. Fiter J, Nolla JM, Navarro MA, Gómez-Vaquero C, Rosel P, Mateo L, Roig-Escofet D. Joint Bone Spine; 2000 Aug; 67(3):199-203. PubMed ID: 10875318 [Abstract] [Full Text] [Related]
29. Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis. Lee HN, Kim A, Kim Y, Kim GT, Sohn DH, Lee SG. Medicine (Baltimore); 2020 Jun 12; 99(24):e20633. PubMed ID: 32541502 [Abstract] [Full Text] [Related]
33. Hormone combination treats women's bone loss. Marwick C. JAMA; 1994 Nov 16; 272(19):1487. PubMed ID: 7966835 [No Abstract] [Full Text] [Related]
34. Height loss rate as a marker of osteoporosis in postmenopausal women with rheumatoid arthritis. Sanila M, Kotaniemi A, Viikari J, Isomäki H. Clin Rheumatol; 1994 Jun 16; 13(2):256-60. PubMed ID: 8088069 [Abstract] [Full Text] [Related]